Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changes

• by Wei Zhao, Lingli Zhou, Ying Gao, Xianghai Zhou, Xueyao Han, Xiuying Zhang, Linong Ji

• July 15, 2026

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

• by Kathryn Wighton

• May 13, 2026

• 5 min

Levels of vascular endothelial growth factor and filtration surgery outcomes in diabetic patients with acute primary angle closure

• by Tianwei Qian, Mingshui Fu, Hao Zhou, Zhihua Zhang, Ying Hu

• July 14, 2026

Editorial: Dynamics of endocrine system dysfunctions and neuro-ophthalmic manifestations: early diagnostic to therapeutic implications

• by Kumar, Dhiraj , Naqvi, Ahmad Abu Turab , Gupta, Rohan , Kumari, Smita , Waseem, Rashid , Hassan, Md. Imtaiyaz

• May 31, 2026